Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00969163 | A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED). | PHASE1 | COMPLETED | 30 | — | — | Oct 1, 2004 | Jun 1, 2005 | Sep 4, 2014 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | 2.5 mg testosterone gel |
| 2 | EXPERIMENTAL | 300 ug testosterone gel |
| 3 | PLACEBO_COMPARATOR | placebo gel |
| Name | Type | Description |
|---|---|---|
| testosterone gel | DRUG | 300 ug or 2.5 mg transdermal testosterone gel daily for 6 weeks |
| Comparator: placebo | DRUG | transdermal placebo gel for 6 weeks |
Inclusion Criteria: * Subject is at least 3 years postmenopausal * Subject is in good general health * Subject is willing to avoid excess alcohol or strenuous physical activity during the study Exclusion Criteria: * Subject has donated a unit of blood or has taken an investigational drug in anoth...